Opaleye Management Inc., 10% Owner at Grace Therapeutics, Inc. (GRCE), bought 7,849 shares at $2.09 ($16K) on 2026-09-29, disclosed to the SEC on 2026-10-01.
Open-market purchase of $16k GRCE by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Negative factors outweigh the positive ones.
| Filing → |
| ACOG | BUY | 2026-09-16 | $1.1M | — | Filing → |
| SLGL | BUY | 2026-09-14 | $207K | — | Filing → |
| GRCE | BUY | 2026-09-10 | $32K | — | Filing → |